Niknam Zahra, Samadi Mahrokh, Ghalibafsabbaghi Ataollah, Chodari Leila
Proteomics Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Nephrology and Kidney Transplant Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
J Cardiovasc Thorac Res. 2022;14(1):34-41. doi: 10.34172/jcvtr.2021.54. Epub 2021 Dec 16.
This research investigates the impact of insulin-like growth factor-I (IGF -I)and exercise on mediators associated with angiogenesis (VEGF-A, TSP-1, and NF-кβ) and capillarization status of the diabetic rats' hearts. Splitting of forty Wistar male rats into five groups occurred as following: control,diabetes, diabetes+IGF-I, diabetes+exercise, and diabetes+exercise+IGF-I.Through intraperitoneal administration of 60 mg/kg streptozotocin, the condition of Type 1diabetes was escalated. After four weeks of treatment with IGF-I (2 mg/kg/day) or treadmill exercise (17 m/min, zero degrees slope, 30 min/day), in the heart, microvascular density and protein levels of VEGF-A, TSP-1, and NF-кβ were determined by H&E staining and ELISA,respectively. Within the diabetic group, observations present a significant decrease in VEGF-A and MVD levels, whereas an increase in the TSP-1 and NF-Κb levels. While these impacts were reversed by either IGF-I or exercise treatments, simultaneous treatment had synergistic effects. Moreover, among diabetic rats, undesirable histologic alterations of the heart were demonstrated, including myonecrosis, interstitial edema, hemorrhage, and mononuclear immune cell infiltration, whereas treatments improved these changes. These data manifest that IGF-I and exercise can increase the cardiac angiogenesis of diabetic rats through increasing expression of VEGF-A, and decreasing TSP-1 and NF-кβproteins level, also can improve myocardial tissue damages.
本研究调查胰岛素样生长因子-I(IGF-I)和运动对与血管生成相关的介质(血管内皮生长因子-A、血小板反应蛋白-1和核因子κB)以及糖尿病大鼠心脏毛细血管化状态的影响。将40只雄性Wistar大鼠分为五组,分组情况如下:对照组、糖尿病组、糖尿病+IGF-I组、糖尿病+运动组和糖尿病+运动+IGF-I组。通过腹腔注射60mg/kg链脲佐菌素使1型糖尿病病情加重。在用IGF-I(2mg/kg/天)或跑步机运动(17m/分钟,零坡度,30分钟/天)治疗四周后,分别通过苏木精-伊红染色和酶联免疫吸附测定法测定心脏中的微血管密度以及血管内皮生长因子-A、血小板反应蛋白-1和核因子κB的蛋白水平。在糖尿病组中,观察结果显示血管内皮生长因子-A和微血管密度水平显著降低,而血小板反应蛋白-1和核因子κB水平升高。虽然这些影响通过IGF-I或运动治疗得到了逆转,但联合治疗具有协同作用。此外,在糖尿病大鼠中,出现了心脏不良组织学改变,包括心肌坏死、间质水肿、出血和单核免疫细胞浸润,而治疗改善了这些变化。这些数据表明,IGF-I和运动可以通过增加血管内皮生长因子-A的表达、降低血小板反应蛋白-1和核因子κB蛋白水平来增加糖尿病大鼠的心脏血管生成,还可以改善心肌组织损伤。